Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
General and administrative	$ 1,933,753	$ 2,948,400
Research and development	458,155	1,825,792
Depreciation and amortization	85,409	86,486
Total operating expenses	2,477,317	4,860,678
Loss from operations	(2,477,317)	(4,860,678)
Other (expense) income
Change in fair value of warrant liabilities	10,039	50,657
Change in fair value of investment option liability	11,398	119,505
Change in fair value of derivative liability		13,000
Interest income (expense), net	696	(11)
Total other income	22,133	183,151
Net loss before income taxes	(2,455,184)	(4,677,527)
Income tax expense	(1,731)
Net loss	(2,456,915)	(4,677,527)
Less preferred dividends attributable to non-controlling interest		12,329
Less deemed dividends attributable to accretion of embedded derivative at redemption value		110,991
Net loss attributable to shareholders	(2,456,915)	(4,800,847)
Other comprehensive loss
Foreign currency translation	17,906	1,968
Comprehensive loss	$ (2,439,009)	$ (4,798,879)
Net loss per share - basic	$ (0.61)	$ (2.31)
Net loss per share - diluted	$ (0.61)	$ (2.31)
Weighted average shares outstanding, basic	4,001,456	2,078,271
Weighted average shares outstanding, diluted	4,001,456	2,078,271